196601-69-1 | (R)-2-Amino-n-benzyl-3-methoxypropanamide

108-24-7    196601-69-1   

lacosamide 

[1]Andurkar,ShridharV.;Stables,JamesP.;Kohn,Harold[TetrahedronAsymmetry,1998,vol.9,#21,p.3841-3854]

[2]Zhang,Jian;Wang,Yi-Yan;Sun,He;Li,Shao-Yu;Xiang,Shao-Hua;Tan,Bin[ScienceChinaChemistry,2020,vol.63,#1,p.47-54]

[3]CurrentPatentAssignee:QILUPHARMACEUTICALGROUPCOLTD-CN106866453,2017,ALocationinpatent:Paragraph0060;0061;0062;0063;0064;0065

[4]Andersen,ThomasL.;Nordeman,Patrik;Christoffersen,HeidiF.;Audrain,Hélène;Antoni,Gunnar;Skrydstrup,Troels[AngewandteChemie-InternationalEdition,2017,vol.56,#16,p.4549-4553][Angew.Chem.,2017,vol.129,p.4620-4624]

[5]CurrentPatentAssignee:ZHUHAIRUNDUPHARMACEUTICALCOLTD-CN112574058,2021,ALocationinpatent:Paragraph0023

[6]CurrentPatentAssignee:INDOCOREMEDIESLIMITED-WO2012/14226,2012,A1Locationinpatent:Page/Pagecolumn20

[7]CurrentPatentAssignee:UCB-WO2006/37574,2006,A1Locationinpatent:Page/Pagecolumn19

[8]CurrentPatentAssignee:FUANPHARMACEUTICALGROUPCOLTD;CHONGQINGFUANPHARMACEUTICALGROUP-CN104030943,2016,BLocationinpatent:Paragraph0125;0126

[9]CurrentPatentAssignee:SUNPHARMACEUTICALINDUSTRIESLIMITED-EP2067765,2009,A2Locationinpatent:Page/Pagecolumn16

[10]CurrentPatentAssignee:SUNPHARMACEUTICALINDUSTRIESLIMITED-EP2067765,2009,A2Locationinpatent:Page/Pagecolumn15-16;16;16-17

[11]CurrentPatentAssignee:SUNPHARMACEUTICALINDUSTRIESLIMITED-US2009/143472,2009,A1Locationinpatent:Page/Pagecolumn9;10

[12]CurrentPatentAssignee:SUNPHARMACEUTICALINDUSTRIESLIMITED-US2009/143472,2009,A1Locationinpatent:Page/Pagecolumn9

[13]CurrentPatentAssignee:GALICANA;TEVAPHARMACEUTICALINDUSTRIESLTD.-US2010/240926,2010,A1Locationinpatent:Page/Pagecolumn6

[14]CurrentPatentAssignee:MEDICHEM,S.A.-US2011/34731,2011,A1Locationinpatent:Page/Pagecolumn7

[15]CurrentPatentAssignee:SUNPHARMACEUTICALINDUSTRIESLIMITED-WO2011/61610,2011,A2Locationinpatent:Page/Pagecolumn14

[16]CurrentPatentAssignee:SUNPHARMACEUTICALINDUSTRIESLIMITED-WO2011/92672,2011,A2Locationinpatent:Page/Pagecolumn15-16

[17]CurrentPatentAssignee:MSNLABORATORIESPRIVATELIMITED-WO2011/99033,2011,A1Locationinpatent:Page/Pagecolumn43

[18]CurrentPatentAssignee:AUROBINDOPHARMALIMITED-WO2011/144983,2011,A2Locationinpatent:Page/Pagecolumn27-28

[19]CurrentPatentAssignee:CURIAINC-EP2399901,2011,A1Locationinpatent:Page/Pagecolumn8-9

[20]CurrentPatentAssignee:CURIAINC-US2011/319649,2011,A1Locationinpatent:Page/Pagecolumn5

[21]CurrentPatentAssignee:SUNPHARMACEUTICALINDUSTRIESLIMITED-WO2012/1710,2012,A1Locationinpatent:Page/Pagecolumn10;13

[22]CurrentPatentAssignee:HETERODRUGSLIMITED-WO2012/46245,2012,A1Locationinpatent:Page/Pagecolumn10

[23]CurrentPatentAssignee:ALEMBICPHARMACEUTICALSLIMITED-WO2013/24383,2013,A1Locationinpatent:Paragraph89;90;91

[24]CurrentPatentAssignee:SUNPHARMACEUTICALINDUSTRIESLIMITED-US2013/102811,2013,A1Locationinpatent:Paragraph0045

[25]CurrentPatentAssignee:AUROBINDOPHARMALIMITED-US2013/123537,2013,A1Locationinpatent:Paragraph0119

[26]CurrentPatentAssignee:JUBILANTPHARMOVALTD-WO2014/155264,2014,A1Locationinpatent:Page/Pagecolumn16

[27]CurrentPatentAssignee:DAVULURIRAMAMOHANRAO;RAO;RAODAVULURIRAMAMOHAN-WO2016/30911,2016,A2Locationinpatent:Page/Pagecolumn13;14

[28]Rao,B.Leelamaheswara;Nowshuddin,Shaik;Jha,Anjali;Divi,MuraliK.;Rao[TetrahedronAsymmetry,2016,vol.27,#11-12,p.487-491]

[29]CurrentPatentAssignee:SHANGHAIHUAYUANPHARMACEUTICALTECHDEVELOPMENT-CN106957239,2017,ALocationinpatent:Paragraph0036;0051-0053

196601-68-0    196601-69-1 

[1]Andurkar,ShridharV.;Stables,JamesP.;Kohn,Harold[TetrahedronAsymmetry,1998,vol.9,#21,p.3841-3854]

[2]LeTiran,Arnaud;Stables,JamesP.;Kohn,Harold[JournalofMedicinalChemistry,2002,vol.45,#21,p.4762-4773]

[3]Andersen,ThomasL.;Nordeman,Patrik;Christoffersen,HeidiF.;Audrain,Hélène;Antoni,Gunnar;Skrydstrup,Troels[AngewandteChemie-InternationalEdition,2017,vol.56,#16,p.4549-4553][Angew.Chem.,2017,vol.129,p.4620-4624]

[4]King,AmberM.;Salomé,Christophe;Dinsmore,Jason;Salomé-Grosjean,Elise;DeRyck,Marc;Kaminski,Rafal;Valade,Anne;Kohn,Harold[JournalofMedicinalChemistry,2011,vol.54,#13,p.4815-4830]

[5]CurrentPatentAssignee:GALICANA;TEVAPHARMACEUTICALINDUSTRIESLTD.-US2010/240926,2010,A1Locationinpatent:Page/Pagecolumn6

[6]CurrentPatentAssignee:MSNLABORATORIESPRIVATELIMITED-WO2011/99033,2011,A1Locationinpatent:Page/Pagecolumn40

598-21-0    196601-69-1   

<i>N</i>-benzyl-2-(2-bromo-acetylamino)-3-methoxy-propionamide 

[1]LeTiran,Arnaud;Stables,JamesP.;Kohn,Harold[JournalofMedicinalChemistry,2002,vol.45,#21,p.4762-4773]

75-07-0    196601-69-1   

<i>N</i>-benzyl-2-ethylamino-3-methoxy-propionamide 

[1]Beguin,Cecile;LeTiran,Arnaud;Stables,JamesP.;Voyksner,RobertD.;Kohn,Harold[BioorganicandMedicinalChemistry,2004,vol.12,#11,p.3079-3096]

100-46-9    196601-69-1 

[1]LeTiran,Arnaud;Stables,JamesP.;Kohn,Harold[JournalofMedicinalChemistry,2002,vol.45,#21,p.4762-4773]

Title: Primary amino acid derivatives: compounds with anticonvulsant and neuropathic pain protection activities.

Journal: Journal of medicinal chemistry 20110714